Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: The AWARE randomized clinical trial

JAMA

Volumn 310, Issue 16, 2013, Pages 1701-1710

  Metsch, Lisa R ^a,b   Feaster, Daniel J ^b   Gooden, Lauren ^a,b   Schackman, Bruce R ^c   Matheson, Tim ^d   Das, Moupali ^d,e   Golden, Matthew R ^f,g   Huffaker, Shannon ^d   Haynes, Louise F ^h   Tross, Susan ⁱ   Malotte, C Kevin ^j   Douaihy, Antoine ^k   Korthuis, P Todd ^l,m   Duffus, Wayne A ⁿ   Henn, Sarah ^o   Bolan, Robert ^p   Philip, Susan S ^d   Castro, Jose G ^b   Castellon, Pedro C ^a,b   McLaughlin, Gayle ^q   Mandler, Raul N ^r   Branson, Bernard ^s   Colfax, Grant N ^d,e   more..

^a Mailman School of Public Health   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^j CALIFORNIA STATE UNIVERSITY   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^m OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁿ UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^o Whitman Walker Health   (United States)

^p LOS ANGELES LGBT CENTER   (United States)

^q Duval County Health Department   (United States)

^r NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^s CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EVIDENCE BASED PRACTICE CENTER; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HIV TEST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUALLY TRANSMITTED DISEASE; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; UNITED STATES; UNSAFE SEX;

EID: 84886305496     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.280034     Document Type: Article

References (32)

1. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data: United States and 6 US dependent areas: 2010 [HIV Surveillance Supplemental Report Vol. 17, No. 3, part A]. Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/library/reports/surveillance/ 2010/surveillance-Report-vol-17-no-3.html. Accessed September 18, 2013.
2. Prejean J, Song R, Hernandez A, et al HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502.
3. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53(5):619-624.
4. National HIV/AIDS strategy for the United States. Office of National AIDS Policy. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf. Accessed April 4, 2013.
5. Moyer VA; US Preventive Services Task Force. Screening for HIV: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(1):51-60.
6. Branson BM, Handsfield HH, Lampe MA, et al Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17.
7. Farnham PG, Hutchinson AB, Sansom SL, Branson BM. Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Rep. 2008;123(suppl 3):51-62.
8. Kamb ML, Fishbein M, Douglas JM Jr, et al Project RESPECT Study Group. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA. 1998;280(13):1161-1167.
9. Lin JS, Whitlock E, O'Connor E, Bauer V. Behavioral counseling to prevent sexually transmitted infections: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008;149(7):497-508.
10. Estimated HIV incidence in the United States, 2007-2010 [HIV Surveillance Supplemental Report Vol. 17, No. 4]. Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/ #supplemental. Accessed March 26, 2013.
11. Metcalf CA, Douglas JM Jr, Malotte CK, et al; RESPECT-2 Study Group. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130-138.
12. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988;26(4):662-667.
13. Mansergh G, Koblin BA, McKirnan DJ, et al Project MIX Study Team. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS Med. 2010;7(8):e1000329.
14. Koblin BA, Mansergh G, Frye V, et al Project MIX Study Team. Condom-use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX. J Acquir Immune Defic Syndr. 2011;58(3):319-327.
15. Colfax G, Vittinghoff E, Husnik MJ, et al EXPLORE Study Team. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol. 2004;159(10):1002-1012.
16. Koblin BA, Chesney MA, Husnik MJ, et al EXPLORE Study Team. High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. Am J Public Health. 2003;93(6):926-932.
17. Enders CK. Applied Missing Data Analysis. New York, NY: The Guilford Press; 2010:265-269.
18. Bernaards CA, Belin TR, Schafer JL. Robustness of a multivariate normal approximation for imputation of incomplete binary data. Stat Med. 2007;26(6):1368-1382.
19. Ratitch B, Lipkovich I, O'Kelly M. Combining analysis results from multiply imputed categorical data. http://pharmasug.org/proceedings/2013/SP/ PharmaSUG-2013-SP03.pdf. Accessed June 27, 2013.
20. Polsky D, Glick H. Costing and cost analysis in randomized controlled trials: caveat emptor. Pharmacoeconomics. 2009;27(3):179-188.
21. Occupational employment statistics (OES). Bureau of Labor Statistics, US Dept of Labor. http://www.bls.gov/oes. Accessed January 31, 2013.
22. Update on implementation of HIV rapid testing in health department supported HIV prevention programs [May 2011]. National Alliance of State and Territorial AIDS Directors (NASTAD). http://www.nachc.com/client/ NASTAD%202010%20Rapid%20Testing%20Report-May%202011.pdf. Accessed September 20, 2013.
23. Jin F, Crawford J, Prestage GP, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS. 2009;23(2):243-252.
24. Wilson DP, Regan DG, Heymer KJ, Jin F, Prestage GP, Grulich AE. Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sex Transm Dis. 2010;37(1):13-17.
25. Cassels S, Menza TW, Goodreau SM, Golden MR. HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington. AIDS. 2009;23(18):2497-2506.
26. Pinkerton SD, Chesson HW, Layde PM; National Institute of Mental Health Multisite HIV Prevention Trial Group. Utility of behavioral changes as markers of sexually transmitted disease risk reduction in sexually transmitted disease/HIV prevention trials. J Acquir Immune Defic Syndr. 2002;31(1):71-79.
27. Peterman TA, Lin LS, Newman DR, et al Project RESPECT Study Group. Does measured behavior reflect STD risk? an analysis of data from a randomized controlled behavioral intervention study. Sex Transm Dis. 2000;27(8):446-451.
28. Fishbein M, Jarvis B. Failure to find a behavioral surrogate for STD incidence: what does it really mean? Sex Transm Dis. 2000;27(8):452-455.
29. Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160-1167.
30. Dilley JW, Woods WJ, Loeb L, et al. Brief cognitive counseling with HIV testing to reduce sexual risk among men who have sex with men: results from a randomized controlled trial using paraprofessional counselors. J Acquir Immune Defic Syndr. 2007;44(5):569-577.
31. Farnham PG, Sansom SL, Hutchinson AB. How much should we pay for a new HIV diagnosis? a mathematical model of HIV screening in US clinical settings. Med Decis Making. 2012;32(3):459-469.
32. Eaton LA, Huedo-Medina TB, Kalichman SC, et al. Meta-analysis of single-session behavioral interventions to prevent sexually transmitted infections: implications for bundling prevention packages. Am J Public Health. 2012;102(11):e34-e44.